FDA Releases Updated Good Clinical Practice Guidance for Trials
Published Date: 9/9/2025
Notice
Summary
The FDA just released the final version of the E6(R3) Good Clinical Practice guidance, which helps drug makers run safer, smarter clinical trials using modern tech and risk-based methods. This update affects anyone involved in clinical trials by encouraging simpler, quality-focused approaches that save time and resources. Get ready to follow these new rules soon to keep trials efficient and reliable!
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Modernized Good Clinical Practice Rules
The FDA released the final E6(R3) Good Clinical Practice guidance, which outlines flexible, modern rules for running clinical trials. It emphasizes quality-by-design, proportionality, and risk-based approaches, encourages use of innovative technology, and finalizes the draft issued June 7, 2023; annex 2 will be added later.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in